Skip to content

The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease

The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease: a Prospective Registry Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03761602
Enrollment
290
Registered
2018-12-03
Start date
2018-12-01
Completion date
2019-12-31
Last updated
2018-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iodine Deficiency in Pregnancy, Iodine Excess in Pregnancy, Selenium Deficiency in Pregnancy, Selenium Excess in Pregnancy

Brief summary

Two hundred and ninety pregnant women with gestational age less than 20 weeks will be recruited in this study. Selenium and iodine conditions, and risk of thyroid disease will be monitored until termination of pregnancy, with pregnancy outcomes recorded.

Detailed description

The study will recruit 290 pregnant women with gestational age less than 20 weeks. Iodine and selenium condition will be evaluated through dietary recall (on base of Chinese food ingredient information) and biochemical examinations (serum iodine concentrations, urinary iodine concentrations, serum selenium concentrations, etc). The nutritional status of iodine and selenium will be monitored and followed up for all the included subjects throughout the pregnancy. The information of thyroid function and level of anti-TPO and anti-TG will be collected. And all the complications (especially thyroid disease) in pregnancy will also be recorded. All pregnant women will be followed up until the termination of pregnancy, with pregnancy outcomes recorded.

Interventions

OTHERNot applicable (for observational studies)

This study is an observational study. No intervention will be administered for research purposes.

Sponsors

Rongrong Li
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Clinical confirmation of being pregnant. * Being within less than 20 weeks of gestationa.

Exclusion criteria

* Being pregnant but over 20 weeks of gestationa. * Mentally or psychologically unstable.

Design outcomes

Primary

MeasureTime frameDescription
risk of thyroid diseaseFrom date of participant inclusion until the date of termination of pregnancy, assessed up to 8 monthsprevalence of thyroid disease (abnormal thyroid function; development of thyroid antibodies)
pregnancy outcomesFrom date of participant inclusion until the date of termination of pregnancy, assessed up to 8 monthsprevalence of premature birth, stillbirth and abortion

Secondary

MeasureTime frameDescription
prevalence of other pregnant complicationsFrom date of participant inclusion until the date of termination of pregnancy, assessed up to 8 monthsprevalence of gestational diabetes mellitus, gestational hypertension, dyslipidemia, etc.
prevalence of thyroid disease in neonatesFrom date of birth to 4 weeks after birthprevalence of thyroid disease (abnormal thyroid function; development of thyroid antibodies,or findings of thyroid nodules) in neonates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026